ArticlePDF Available

Multiplex PCR for Rapid Detection of Genes Encoding Class A Carbapenemases

Authors:

Abstract

In recent years, there have been increasing reports of KPC-producing Klebsiella pneumoniae in Korea. The modified Hodge test can be used as a phenotypic screening test for class A carbapenamase (CAC)-producing clinical isolates; however, it does not distinguish between carbapenemase types. The confirmation of type of CAC is important to ensure optimal therapy and to prevent transmission. This study applied a novel multiplex PCR assay to detect and differentiate CAC genes in a single reaction. Four primer pairs were designed to amplify fragments encoding 4 CAC families (SME, IMI/NMC-A, KPC, and GES). The multiplex PCR detected all genes tested for 4 CAC families that could be differentiated by fragment size according to gene type. This multiplex PCR offers a simple and useful approach for detecting and distinguishing CAC genes in carbapenem-resistant strains that are metallo-β-lactamase nonproducers.
ISSN 2234-3806 eISSN 2234-3814
359
http://dx.doi.org/10.3343/alm.2012.32.5.359
www.annlabmed.org
Ann Lab Med 2012;32:359-361
http://dx.doi.org/10.3343/alm.2012.32.5.359
Brief Communication
Clinical Microbiology
Multiplex PCR for Rapid Detection of Genes Encoding
Class A Carbapenemases
Sang Sook Hong, M.D.
1
, Kyeongmi Kim, M.D.
1
, Ji Young Huh, M.D.
1
, Bochan Jung, M.D.
2
, Myung Seo Kang, M.D.
1
,
and Seong Geun Hong, M.D.
1
Department of Laboratory Medicine
1
, CHA Bundang Medical Center, CHA University, Seongnam; Department of Laboratory Medicine
2
, CHA Gumi Medical
Center, CHA University, Gumi, Korea
In recent years, there have been increasing reports of KPC-producing
Klebsiella pneu-
moniae
in Korea. The modied Hodge test can be used as a phenotypic screening test for
class A carbapenamase (CAC)-producing clinical isolates; however, it does not distinguish
between carbapenemase types. The conrmation of type of CAC is important to ensure
optimal therapy and to
prevent transmission. This study applied a novel multiplex PCR as-
say to detect and differentiate CAC genes in a single reaction. Four primer pairs were de-
signed to amplify fragments encoding
4 CAC families (SME, IMI/NMC-A, KPC, and GES).
The multiplex PCR detected all genes tested for
4 CAC families that could be differentiated
by fragment size according to gene type. This multiplex PCR offers
a simple and useful
approach for detecting and distinguishing CAC genes in carbapenem-resistant strains that
are metallo-
β
-lactamase nonproducers.
Key Words:
Carbapenemase, Multiplex PCR, KPC, GES
Received: January 26, 2012
Revision received: May 21, 2012
Accepted: July 9, 2012
Corresponding author: Seong Geun Hong
Department of Laboratory Medicine, CHA
Bundang Medical Center, CHA University,
59 Yatap-ro, Bundang-gu, Seongnam
463-712, Korea
Tel: +82-31-780-5463
Fax: +82-31-780-5476
E-mail: hlseo@cha.ac.kr
© The Korean Society for Laboratory Medicine.
This is an Open Access article distributed under
the terms of the Creative Commons Attribution
Non-Commercial License (http://creativecom-
mons.org/licenses/by-nc/3.0) which permits
unrestricted non-commercial use, distribution,
and reproduction in any medium, provided the
original work is properly cited.
Carbapenems are important antibiotics for the treatment of in-
fections caused by multidrug-resistant gram-negative bacilli [
1,
2]; however, carbapenem-resistance is increasing, causing in-
fections that are difcult to treat [
2-4]. Bacterial production of
carbapenemases is one of the most important mechanisms of
carbapenem resistance [
1]. There are 3 molecular classes of
carbapenemases: A (penicill
inases); B (metallo-
β
-lactamases,
MBLs); and D (oxacillinases). The class A carbapenemases
(CACs) include the SME, IMI/NMC-A, SFC, BIC, KPC, and some
type of GES family proteins. The genes for the SME, IMI/NMC-A
(except IMI-
2), SFC, and BIC enzymes are chromosomal, and
the genes for KPC and GES are carried on plasmids [
1]. KPC
producers have caused severe treatment problems in hospitals
around New
York and have also been reported in Europe, South
America, and China [
5-8]. In Korea, KPC-producing
Klebsiella
pneumoniae
have rarely been detected. However, several cases
were reported in
2010 and 2011 (Interscience Conference on
Antimicrobial Agents and Chemotherapy
2011 poster c2-652,
unpublished observation) [
9, 10].
The modied Hodge test (MHT) can be used as a phenotypic
conrmatory test f
or suspected carbapenemase production in
Enterobacteriaceae
[11]. However, it is reported that the MHT
shows approximately
25% false positive results among carbap-
enemase nonproducers, mainly AmpC hyperproducers and
strains harboring CTX-M [
12]. Moreover, it does not distinguish
between carbapenemase types or CAC types.
The major concern from the therapeutic and epidemiologic
perspective is with
transmissible and not chromosomal carbap-
enemases [
1, 2], and this information cannot be acquired by
the phenotypic methods. Conrmation of the CAC type is impor-
tant to ensure optimal therapy and to prevent transmission [
3].
In this study, we developed a multiplex PCR assay to detect and
differentiate multiple CAC genes in a single reaction.
Eleven CAC producers (1 SME-producing
Serratia marce-
Hong SS, et al.
Multiplex PCR for class A carbapenemases
360
www.annlabmed.org
http://dx.doi.org/10.3343/alm.2012.32.5.359
scens
, 2 IMI/NMC-A-producing
Enterobacter cloacae
, 2 KPC-
producing
Enterobacteriaceae
, and 6 GES-producing
Klebsiella
pneumoniae
); 7 MBL producers (3 VIM-producing
Pseudomo-
nas aeruginosa
, 2 IMP-producing
P. aeruginosa
, 1 IMP-produc-
ing
Acinetobacter baumannii
, and 1 SIM-producing
A. bauman-
nii
); and 5 non-carbapenemase-producing
Enterobacteriaceae
were studied (Table
1).
The bacterial cells
were lysed by heating at 95
°
C for 10 min,
and cellular debris was removed by centrifugation at
13,000 rpm
for
5 min. The supernatant was used as the source of amplica-
tion templates. PCR was performed with a nal volume of
20
μ
L
in
0.2 mL thin-walled tubes (Accupower
TM
HotStart PCR PreMix;
Bioneer, Daejeon, Korea).
We designed
4 primer pairs for 4 CAC families (SME, IMI/NMC-
A, KPC, and GES). The
genes encoding IMI and NMC-A type
CACs are similar to each other and could not be differentiated by
conventional PCR. Therefore, a single primer pair for the detection
of these
2 CAC families was designed. The SFC-1 and the BIC-1
enzymes have been found in environmental isolates, and the cor-
responding genes are chromosomally encoded [
13, 14]. For this
reason, we did not design pairs of primers fo
r these genes. The
primers used in this study were GES primers for
bla
GES1-9
and
bla
GES11-20
(GES-F: 5
-GCTTCATTCACGCACTATT-3
; GES-MR:
5
-CGATGCTAGAAACCGCTC-3
; product size: 323 bp), IMI/NMC-
A primers for
bla
IMI1-3
and
bla
NMC-A
(IMI(NMC)-F1: 5
-TGCGGTC-
GATTGGAGATAAA-
3
; IMI(NMC)-R1: 5
-CGATTCTTGAAGCTTCT-
GCG-
3
; product size: 399 bp), SME primers for
bla
SME1-3
(SME-F1:
5
-ACTTTGATGGGAGGATTGGC-3
; SME-R1: 5
-ACGAATTCGAG-
CATCACCAG-
3
; product size: 551 bp), and KPC primers for
bla
KPC2-13
(KPCF2: 5
-GTATCGCCGTCTAGTTCTGC-3
; KPCFR:
5
-GGTCGTGTTTCCCTTTAGCC-3
; product size 638 bp). The PCR
program consisted of an initial denaturation step at
94
°
C for 5 min,
followed by
25 cycles of DNA denaturation at 94
°
C for 30 sec,
primer annealing at
50
°
C for 30 sec, and primer extension at 72
°
C
for
1 min. After the last cycle, a nal extension step at 72
°
C for 7
min was added.
The GenBank nucleotide sequence accession numbers for
the sequences studied here were as follows: GES-
1 (AF156486);
GES-
2 (AF326355); GES-3 (AB113580); GES-4 (AB116260); GES-5
(AY
494717); GES-6 (AY494718); GES-7 (IBC-1, AF208529); GES-8
(IBC-
2, AF329699); GES-9 (AY920928); GES-11 (FJ854362); GES-
12 (FN554543); GES-13 (GU169702); GES-14 (GU207844); GES-
15 (GU208678); GES-16 (HM173356); GES-17 (HQ874631); GES-
18 (JQ028729); GES-19 (JN596280); GES-20 (JN596280); IMI-1
(U
50278); IMI-2 (DQ173429); IMI-3 (GU015024); NMC-A (Z21956);
SME-
1 (Z28968); SME-2 (AF275256); SME-3 (AY584237); KPC-2
(AY
034847); KPC-3 (AF395881); KPC-4 (AY700571); KPC-5
(EU
400222); KPC-6 (EU555534); KPC-7 (EU729727); KPC-8
(FJ
234412); KPC-9 (FJ624872); KPC-10 (GQ140348); KPC-11
(HM
066995); KPC-12 (HQ342889); and KPC-13 (HQ342890).
The CAC families could be differentiated into
4 groups, SME,
IMI/NMC-A, KPC, and GES, by the PCR product size (Fig.
1).
None of the non-CAC producers included in this study produced
PCR product bands. Not all genotypes of CAC were tested: only
SME-
1, IMI-1, NMC-A, KPC-2, KPC-3, and GES-5-type enzyme-
producing strain
s were included in this study. The primers for
the genotypic detection of SME, KPC and GES enzymes were
exactly complementary to the corresponding GenBank sequences,
but the primers for IMI/NMC-A were not complementary at
1
base each in the forward and reverse sequences of IMI-
3 and
NMC-A. Therefore, it is somewhat uncertain whether this multi-
plex PCR assay would be able to detect all of the geno
types of
CACs described above.
Table 1. Bacterial strains used for class A carbapenemase multiplex
PCR
Enzyme family
N of
strains
Strain
Enzyme
type*
Source
Class A carbapenemase
SME 1
Serratia marcescens
SME-1 CRAB
IMI 1
Enterobacter cloacae
IMI-1 CRAB
NMC-A 1
Enterobacter cloacae
NMC-A CRAB
KPC 1
Klebsiella pneumoniae
KPC-2 CRAB
1
Escherichia coli
KPC-3 CRAB
GES 6
Klebsiella pneumoniae
GES-5 like Our laboratory
Metallo-ß-lactamase
VIM 3
Pseudomonas aeruginosa
VIM-2 like Our laboratory
IMP 2
Pseudomonas aeruginosa
IMP-6 like Our laboratory
1
Acinetobacter baumannii
IMP-25 like Our laboratory
SIM 1
Acinetobacter baumannii
SIM-1 like Our laboratory
Non-carbapenemase
ESBL 1
Escherichia coli
TEM type Our laboratory
1
Escherichia coli
SHV type Our laboratory
1
Klebsiella pneumoniae
SHV type Our laboratory
1
Citrobacter freundii
TEM type Our laboratory
ESBL+AmpC
(EBC
)
1
Klebsiella pneumoniae
SHV type Our laboratory
*ESBLs were detected by CLSI phenotypic conrmatory tests and type spe-
cic PCR;
CRAB, Center for Research in Anti-Infectives and Biotechnology,
Department of Medical Microbiology and Immunology, School of Medicine,
Creighton University, Omaha, Nebraska;
EBC is a group of AmpC
β
-lactamase
originated from
E. cloacae
.
Abbreviation: ESBL, extended-spectrum
β
-lactamase.
Hong SS, et al.
Multiplex PCR for class A carbapenemases
361
http://dx.doi.org/10.3343/alm.2012.32.5.359
www.annlabmed.org
In summary, this multiplex PCR method appears to be a sim-
ple and useful approach for detecting and distinguishing CAC
genes in MBL-negative carbapenem-resistant strains. Therefore,
this method should be helpful for characterization of CACs and
prevention of the spread of pathogens producing these enzymes.
Authors’ Disclosures of Potential Conicts of
Interest
No potential conicts of interest relevant to this article were re-
ported.
Acknowledgement
We thank Dr. Kenneth S. Thomson (Center for Research in Anti-
Infectives and Biotechnology, Department of Medical Microbiol-
ogy and Immunology, School of Medicine, Creighton University,
Omaha, Nebraska) for providing class A carbapenemase-pro-
ducing isolates.
REFERENCES
1. Patel G and Bonomo RA. Status report on carbapenemases: challenges
and prospects. Expert Rev Anti Infect Ther 2011;9:555-70.
2. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant
En-
terobacteriaceae:
epidemiology and prevention. Clin Infect Dis 2011;53:
60-7.
3. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M,
et al. Acquired carbapenemases in Gram-negative bacterial pathogens:
detection and surveillance issues. Clin Microbiol Infect 2010;16:112-22.
4. Cornaglia G and Rossolini GM. The emerging threat of acquired car-
bapenemases in Gram-negative bacteria. Clin Microbiol Infect 2010;16:
99-101.
5. Ambretti S, Gaibani P, Caroli F, Miragliotta L, Sambri V. A carbapenem-
resistant
Klebsiella pneumoniae
isolate harboring KPC-1 from Italy. New
Microbiol 2010;33:281-2.
6. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP. First
identication of
Pseudomonas aeruginosa
isolates producing a KPC-type
carbapenem-hydrolyzing
β
-lactamase. Antimicrob Agents Chemother
2007;51:1553-5.
7. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-
2 in a
Klebsiella pneumoniae
isolate from China. Antimicrob Agents
Chemother 2007;51:763-5.
8. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW,
Steward CD, et al. Novel carbapenem-hydrolyzing
β
-lactamase, KPC-1,
from a carbapenem-resistant strain of
Klebsiella pneumoniae
. Antimi-
crob Agents Chemother 2001;45:1151-61.
9. Rhee JY, Park YK, Shin JY, Choi JY, Lee MY, Peck KR, et al. KPC-pro-
ducing extreme drug-resistant
Klebsiella pneumoniae
isolate from a pa-
tient with diabetes mellitus and chronic renal failure on hemodialysis in
South Korea. Antimicrob Agents Chemother 2010;54:2278-9.
10. Roh KH, Lee CK, Sohn JW, Song W, Yong D, Lee K. Isolation of a
Kleb-
siella pneumoniae
isolate of sequence type 258 producing KPC-2 car-
bapenemase in Korea. Korean J Lab Med 2011;31:298-301.
11. Thomson KS. Extended-Spectrum-
β
-Lactamase, AmpC, and Carbapen-
emase issues. J Clin Microbiol 2010;48:1019-25.
12. Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. Sensitive
screening tests for suspected class A carbapenemase production in
species of
Enterobacteriaceae
. J Clin Microbiol 2009;47:1631-9.
13. Girlich D, Poirel L, Nordmann P. Novel ambler class A carbapenem-hy-
drolyzing
β
-lactamase from a
Pseudomonas fluorescens
isolate from
the Seine River, Paris, France. Antimicrob Agents Chemother 2010;54:
328-32.
14. Henriques I, Moura A, Alves A, Saavedra MJ, Correia A. Molecular
characterization of a carbapenem-hydrolyzing class A
β
-lactamase,
SFC-1, from
Serratia fonticola
UTAD54. Antimicrob Agents Chemother
2004;48:2321-4.
700 bp
500 bp
400 bp
300 bp
200 bp
100 bp
KPC
SME
IMI/NMC-A
GES
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Fig. 1. Results of multiplex PCR for class A carbapenemase (CAC)-
producing strains. Multiplex PCR products were separated on a 2%
agarose gel. Lanes 1 and 14 show the 100-bp DNA ladder; lane 2,
the PCR product of the negative control (distilled water); lanes 3
and 4, KPC-type enzyme-producing strains; lane 5, SME-type; lanes
6 and 7, NMC-A and IMI-type, respectively; lanes 8-13, GES-type.
The amplied product from each PCR is indicated on the right, and
the size of the marker in base pairs is shown on the left.
... Worldwide, Carbapenem-Resistant Enterobacteriaceae (CRE) infections pose a serious threat to the public's health and are linked to high morbidity and mortality [10]. Despite numerous measures to stop the spread of the diseases caused by CRE, the frequency of CRE varies greatly among various animals and geographical regions [10]. ...
... Worldwide, Carbapenem-Resistant Enterobacteriaceae (CRE) infections pose a serious threat to the public's health and are linked to high morbidity and mortality [10]. Despite numerous measures to stop the spread of the diseases caused by CRE, the frequency of CRE varies greatly among various animals and geographical regions [10]. ...
... Molecular detection of different carbapenemases (Class A-KPC, IMI, SME, SPM, GES; Class B-VIM, IMP, NDM, SPM, GIM, SIM; and Class D-OXA-48 like variants) (30); ESBLs (TEM, SHV, and OXA-1/9); plasmid-mediated AmpC β-lactamases (MOX, CMY, DHA, ACC, MIR/ACT, and FOX) (31); 16S rRNA methylase-encoding genes (rmtA, rmtB, rmtC, rmtD, and armA) (32); PMQR genes (qnrA, qnrB, qnrC, qnrD, qnrS, qepA, and aac(6′)-Ib-cr) (33); and integrons (class 1, 2, and 3) were determined by multiplex PCR (34). Furthermore, singlex PCR and Sanger sequencing helped in determining the alleles of bla NDM , bla KPC , bla Oxa-48like variants, bla CTX-M , bla SHV , bla TEM , bla Oxa-ESBL , bla SFO , and bla CMH genes (Table S1). ...
Article
Full-text available
Whole genome sequence-based molecular characterization of blood isolates of carbapenem-resistant Enterobacter cloacae complex from ICU patients in Kolkata, India, during 2017–2022: emergence of phylogenetically heterogeneous Enterobacter hormaechei subsp. xiangfangensis
... Molecular detection of different carbapenemases (Class A-KPC, IMI, SME, SPM, GES; Class B-VIM, IMP, NDM, SPM, GIM, SIM; and Class D-OXA-48 like variants) (30); ESBLs (TEM, SHV, and OXA-1/9); plasmid-mediated AmpC β-lactamases (MOX, CMY, DHA, ACC, MIR/ACT, and FOX) (31); 16S rRNA methylase-encoding genes (rmtA, rmtB, rmtC, rmtD, and armA) (32); PMQR genes (qnrA, qnrB, qnrC, qnrD, qnrS, qepA, and aac(6′)-Ib-cr) (33); and integrons (class 1, 2, and 3) were determined by multiplex PCR (34). Furthermore, singlex PCR and Sanger sequencing helped in determining the alleles of bla NDM , bla KPC , bla Oxa-48like variants, bla CTX-M , bla SHV , bla TEM , bla Oxa-ESBL , bla SFO , and bla CMH genes (Table S1). ...
Article
Full-text available
Blood-borne infections caused by the carbapenem-resistant Enterobacter cloacae complex (CR-ECC) are major public threats with respect to the challenges encountered during treatment. This study describes the whole genome sequencing-based molecular characteristics of blood isolates ( n = 70) of CR-ECC from patients admitted to the intensive care unit of tertiary care hospitals in Kolkata, India, during 2017–2022 with respect to species identification, antimicrobial resistance (AMR) profiling, mechanism of drug resistance, and molecular subtypes. Vitek2 MALDI and species-specific PCR identified Enterobacter hormaechei subsp. xiangfangensis (47.14%) as the emerging CR-ECC subspecies in Kolkata. The predominating carbapenemase and extended-spectrum β-lactamase genes found were bla NDM-1 (51.42%) and bla CTX-M-15 (27%), respectively. Besides, bla NDM-4 , bla NDM-5 , bla NDM-7 , bla CMH-3 , bla SFO-1 , bla OXA-181 , bla OXA-232 , bla KPC-3 , and bla DHA-7 genes were also detected, which were not previously reported from India. A multitude of Class 1 integrons (including In180, In4874, In4887, and In4888, which were novel) and plasmid replicon types (IncFIB, IncFII, IncX3, IncHI1-HI2, IncC, and IncR) involved in AMR dissemination were identified. Reverse transcription-PCR and western blot revealed that carbapenem resistance in non-carbapenemase-producing CR-ECC isolates was contributed by elevated levels of ampC , overexpression of acrAB, and loss of ompF . A total of 30 distinct sequence types (STs) were ascertained by multi-locus sequence typing; of which, ST2011, ST2018, ST2055, ST2721, and ST2722 were novel STs. Pulsed-field gel electrophoresis analysis showed heterogeneity (69 pulsotypes with a similarity coefficient of 48.40%) among the circulating isolates, suggesting multiple reservoirs of infections in humans. Phylogenetically and genetically diverse CR-ECC with multiple AMR mechanisms mandates close monitoring of nosocomial infections caused by these isolates to forestall the transmission and dissemination of AMR. IMPORTANCE The emergence and extensive dissemination of the carbapenem-resistant Enterobacter cloacae complex (CR-ECC) have positioned it as a critical nosocomial global pathogen. The dearth of a comprehensive molecular study pertaining to CR-ECC necessitated this study, which is the first of its kind from India. Characterization of blood isolates of CR-ECC over the last 6 years revealed Enterobacter hormaechei subsp. xiangfangensis as the most prevalent subsp., exhibiting resistance to almost all antibiotics currently in use and harboring diverse transmissible carbapenemase genes. Besides the predominating bla NDM-1 and bla CTX-M-15 , we document diverse carbapenemase and AmpC genes, such as bla NDM-4 , bla NDM-7 , bla OXA-181 , bla OXA-232 , bla KPC-3 , bla CMH-3 , bla SFO-1 , and bla DHA-7 , in CR-ECC, which were not previously reported from India. Furthermore, novel integrons and sequence types were identified. Our findings emphasize the need for strengthened vigilance for molecular epidemiological surveillance of CR-ECC due to the presence of epidemic clones with a phylogenetically diverse and wide array of antimicrobial resistance genes in vulnerable populations.
... DNA extraction was performed through thermal lysis using the InstaGene Matrix kit (Bio-Rad ® ). CRE strains were screened by PCR assays for genes encoding the most frequent β-lactamase: class A, B and D carbapenemases (bla GES , bla KPC , bla IMI bla NDM , bla VIM , bla IMP and bla OXA-48 ), extended-spectrum β-lactamases (ESBLs) (bla CTX-M , bla TEM and bla SHV ) and OXA-1-like ESBL as previously described [8][9][10][11][12]. ...
Article
Full-text available
Carbapenem resistant Enterobacteriaceae (CRE) are major human pathogens because, these cause high number of difficult-to-treat infections. Allogeneic hematopoietic stem cell transplant (AHSCT) recipients are highly exposed to these type of bacteria. The aim of our study was to investigate prevalence of CRE colonization in AHSCT patients and to determine genes encoding carbapenem resistance. A retrospective study conducted between January 2015 and December 2019, involved 55 patients colonized with CRE strains. We determined the rate of antibiotic resistance according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the carbapenem resistance genes by PCR assays for genes encoding most frequent β-lactamases namely, blaGES, blaKPC, blaIMI, blaNDM, blaVIM, blaIMP and blaOXA-48. Eighty-one episodes of CRE colonization were recorded in 55 patients, mainly suffering from acute leukaemia (30%) and aplastic anemia (26%). History of hospitalization was noted in 80 episodes. Prior antibiotic treatment, severe neutropenia and corticosteroid therapy were respectively found in 94%, 76% and 58% of cases. Among the 55 patients, six patients (11%) developed a CRE infection. The CRE responsible for colonization were carbapenemase producers in 90% of cases. They belonged mostly to Klebsiella pneumoniae (61/81) and Escherichia coli species (10/81). Antibiotic resistance rates were 100% for ertapenem, 53% for imipenem, 42% for amikacin, 88% for ciprofloxacin and 27% for fosfomycin. Molecular study showed that blaOXA-48 gene was the most frequent (60.5%), followed by blaNDM (58%). Thirty-five (43%) strains were co-producers of carbapenemases. In our study, we report a high rate of CRE intestinal colonization in AHSCT recipients of our center.
... For isolates showing resistance or reduced susceptibility to at least one of the tested carbapenem antibiotics (imipenem, meropenem, and ertapenem), the bla KPC , bla OXA-48 , bla NDM-1 and bla IMI genes encoding the most prevalent carbapenemases in Tunisia were investigated [27]. Genes encoding resistance to tetracycline (tetA, tetB, and tetC), sulfamethoxazole (sul1, sul2, and sul3), fluoroquinolones (plasmid-mediated quinolone resistance (PMQR) genes) (qnrA, qnrB, qnrD, qnrS, aac(6 0 )-Ib, and qepA), and colistin (mcr-1 and mcr-2) were analysed by PCR [26]. ...
Article
Full-text available
This study sought to investigate the occurrence and subsequently to characterize extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae from urban and rural stagnant water samples during the wet season (December to February) in several regions of northern Tunisia. From 56 stagnant water samples, 14 ESBL-producing Enterobacteriaceae were recovered, including 9 Escherichia coli, 3 Klebsiella pneumoniae, and 2 K. oxytoca. Most isolates were multidrug-resistant, with ESBL production primarily encoded by blaCTX-M-15 (n = 8) and blaCTX-M-1 (n = 4) followed by blaCTX-M-55 (n = 1) and blaTEM-26 (n = 1). One K. pneumoniae isolate co-harbored blaKPC and blaCTX-M-15 genes. Class 1 integrons were detected in 4 isolates, however, sul1, sul2, and aac(6′)-Ib-cr genes were detected in eleven, two, and four isolates, respectively. The nine E. coli isolates belonged to seven sequence types namely, B2/ST131 (3 isolates), A/ST164, A/ST10, A/ST224, A/ST38, A/ST155, and A/ST69 (each of them one isolate). The three K. pneumoniae isolates were assigned to three sequence types: ST101, ST405 (harboring CTX-M-15 and KPC), and ST1564. Overall, the phenotypic and genotypic traits of collected isolates mirror the molecular epidemiology of ESBL-producing enterobacteria in Tunisia and highlight the potential role of stagnant water in both urban and rural areas as a reservoir of ESBL-producing Enterobacteriaceae.
... Carbapenemase-producing isolates confirmed by phenotypic tests were subjected to PCR assay to ensure the presence of the following resistance genes: ESBLs genes: bla TEM [18], blaSHV [19], blaCTX-MU [20]; carbapenemases class A: blaKPC, blaGES, blaIMI and blaSME [21]; carbapenemases class D: blaOXA-48 [22]. Isolates positive for imipenem-EDTA combined disc test were further tested for the presence of class B carbapenemases (metallo-β-lactamases) genes: blaIMP, blaGIM, blaSPM, blaSIM, blaVIM and blaNDM [23]. ...
Article
Full-text available
Introduction: The spread of multidrug-resistant bacteria, particularly carbapenem-resistant Gram-negative bacilli (CR-GNB), has become a serious challenge for clinicians due to limited therapeutic options. The aim of the study was to investigate the prevalence of carbapenemase production among clinical isolates recovered from 352 samples collected in Tebessa hospital, Algeria. Methodology: Bacterial isolates were identified by 16S RNA gene sequencing and susceptibility to antibiotics was determined by disk diffusion method. Carbapenem-resistant isolates were screened for carbapenemase production using modified carba Nordmann-Poirel test, modified Hodge test and imipenem-EDTA combined disc test. Extended-spectrum β-lactamases (ESBL) were detected using double-disk synergy test. Molecular characterization of carbapenemases and ESBL genes was performed by polymerase chain reaction (PCR) and sequencing. Results: A total of 85 Gram-negative bacilli isolates were recovered mainly from urine samples and were identified as: Klebsiella pneumoniae (17.65%), Serratia odorifera (15.29%), Escherichia coli (12.94%), Raoultella ornithinolytica, Enterobacter cloacae (11.76%), Serratia marcescens (10.59%), Morganella morganii (7.06%), Proteus mirabilis (5.88%), Acinetobacter baumannii (4.70%) and Pseudomonas aeruginosa (2.35%). All strains were resistant or intermediate to imipenem and/or ertapenem. ESBL, carbapenemase and metallo-beta-lactamases (MBL) phenotypes were detected in 19 (22.35%), 9 (10.59%) and 2 (2.35%) GNB isolates, respectively. PCR results in nine carbapenemase-producing GNB strains chosen showed the presence of one to four carbapenemase genes (blaGES, blaSME, blaNDM-1, blaVIM, blaGIM, blaSPM, blaOXA-48) in four strains; however, seven strains had at least one ESBL gene (blaTEM-1, blaCTXM-15, blaSHV). Conclusions: In this study, we report the first incidence of blaNDM-1 gene in Enterobacter cloacae isolated from urine sample in Algeria.
... Carbapenemase production in the isolates was detected by Carba NP test (bioMerieux Diagnostics, France). Molecular detection of Class A and Class B carbapenemases was done by multiplex PCR as described per reference 10,11 . Previously characterized and published isolates were considered as positive controls for both ESBL and carbapenemase genes 12 . ...
Article
Full-text available
Background & objectives: During the course of a retrospective survey on healthcare associated infections (HAIs) due to carbapenem-resistant organisms, an unusual prevalence of HAIs due to carbapenem-resistant Providencia stuartii (CRPS) was found. Hence this study aimed to conduct the occurrence of P. stuartii associated HAIs with special reference to the drug resistance profiling of these isolates. Methods: Of the eight total HAI cases (7.5% of total HAIs and 33.3% of HAIs due to Enterobacterales) of CRPS infections included in this study, three were reported from ventilator-associated pneumonia (VAP), three were surgical site infections (SSIs), one was a catheter-associated urinary tract infection (CAUTI) and one was a bloodstream infection. All the eight CRPS isolates were tested for extended-spectrum β-lactamases production, AmpC hyperproduction as well as carbapenem resistance. Typing of the isolates was performed by repetitive extragenic palindromic polymerase chain reaction (REP-PCR). Results: All the eight isolates of CRPS were found to be AmpC hyperproducers, carbapenemase producers, and harboured chromosomally located blaNDM in seven isolates and blaIMP genes in one. All the cases with CRPS infections had prior history of colistin therapy along with prolonged hospital stay (>20 days). The cases were located in five different wards/intensive care unit (ICU) within the hospital in one year. However, strain typing by REP-PCR revealed 100 per cent similarity and clonal relatedness in all the seven isolates carrying blaNDM genes. Interestingly, routine hospital surveillance revealed a high carriage of P. stuartii in the axilla of patients admitted to the ICU. Interpretation & conclusions: The study findings suggest CRPS as an important cause of HAIs. This organism often goes unnoticed due to the burden of carbapenem resistance in other Enterobacterales and non-fermenters.
... As part of the active surveillance performed by the INVIFAR network, centers sent relevant carbapenem-resistant Gram negatives to the coordinating laboratory. In the clinical isolates received from centers, polymerase chain reaction (PCR) was performed to detect the most frequent carbapenemase-encoding genes previously reported in this population [15], that is, bla NDM-1 , bla KPC , bla VIM , bla IMP , and bla OXA-48-like [16,17] in E. coli and K. pneumoniae isolates; bla OXA-23 and bla OXA-24 in A. baumannii isolates [18,19]; and bla VIM , bla IMP , and bla GES in P. aeruginosa isolates [10]. ...
Article
Full-text available
We analyzed the antimicrobial resistance (AMR) data of 6519 clinical isolates of Escherichia coli (n = 3985), Klebsiella pneumoniae (n = 775), Acinetobacter baumannii (n = 163), Pseudomonas aeruginosa (n = 781), Enterococcus faecium (n = 124), and Staphylococcus aureus (n = 691) from 43 centers in Mexico. AMR assays were performed using commercial microdilution systems (37/43) and the disk diffusion susceptibility method (6/43). The presence of carbapenemase-encoding genes was assessed using PCR. Data from centers regarding site of care, patient age, and clinical specimen were collected. According to the site of care, the highest AMR was observed in E. coli, K. pneumoniae, and P. aeruginosa isolates from ICU patients. In contrast, in A. baumannii, higher AMR was observed in isolates from hospitalized non-ICU patients. According to age group, the highest AMR was observed in the ≥60 years age group for E. coli, E. faecium, and S. aureus, and in the 19–59 years age group for A. baumannii and P. aeruginosa. According to clinical specimen type, a higher AMR was observed in E. coli, K. pneumoniae, and P. aeruginosa isolates from blood specimens. The most frequently detected carbapenemase-encoding gene in E. coli was blaNDM (84%).
... Detection and identification of carbapenemaseencoding genes DNA extraction was carried out by InstaGeneÔ matrix (BioRad, California,USA) following the manufacturer's instructions. For isolates resistant to imipenem and meropenem, bla VIM , bla NDM , bla KPC , bla IMP , bla IMI , bla GES , and bla OXA48 genes were investigated by PCR as previously reported [18][19][20][21]. Seven isolates harboring bla VIM and bla GES genes, were randomly taken and sequenced. ...
Article
Full-text available
Pseudomonas aeruginosa is one of the major infectious agents in burn patients. Globally, high rates of antimicrobial resistance in P. aeruginosa have been reported, which is a cause of concern. The objective of this study was to determine the rate of resistance to carbapenems in P. aeruginosa isolates recovered from burn patients in Tunisia, to search genes encoding for carbapenemases and to determine their epidemiological markers (serotypes). A retrospective study was conducted in the Burn Intensive Care Unit (BICU) of the Trauma and Burn Centre of Ben Arous, Tunisia, and P. aeruginosa isolates collected from burn patients, from January to December 2018 were investigated. Carbapenemase screening was performed by Carbapenem Inactivation Method (CIM) and by EDTA-disk test for all carbapenem resistant isolates. Genes encoding carbapenemases (blaVIM, blaIMP, blaGES, blaNDM, and blaKPC) were investigated by PCR and selected carbapenemase genes were sequenced. During the study period, 104 non duplicated P. aeruginosa isolates were recovered. Most of them were isolated from skin samples (45.1%) and blood culture (22.1%) and belonged to O:11 (19.2%), O:12, and O:5 (12.5%, each) serotypes. High rates of resistance were observed for carbapenems (64.4%). Among the 67 carbapenem resistant isolates, 58 (86.5%) harbored blaVIM gene and 55 (82%) blaGES gene; in addition, 48 (71.6%) co-harbored blaVIM and blaGES genes. After sequencing, the blaVIM-2 and blaGES-5 gene variants were identified in seven randomly selected isolates. To the best of our knowledge, this is the first description of P. aeruginosa simultaneously harboring blaVIM-2 and blaGES-5 genes.
Article
Full-text available
Pseudomonas aeruginosa and Klebsiella pneumoniae are notorious for their resistance to antibiotics and propensity for biofilm formation, posing significant threats to human health. Epsilon-poly-L-lysine (ε-PL) emerges as a naturally occurring antimicrobial poly(amino acid), which positions it as a prospective agent for addressing challenges linked to multidrug resistance. ε-PL symbolizes a promising avenue in the pursuit of efficacious therapeutic strategies and warrants earnest consideration within the realm of clinical treatment. Thus, our objective was to determine the antibiotic susceptibility profiles of 38 selected P. aeruginosa and ESBL-producing K. pneumoniae clinical isolates and determine the ability of ε-PL to inhibit biofilm formation. After PCR analysis, detection of genes related to β-lactamases was observed among the selected isolates of P. aeruginosa [blaSPM (35.7%), blaKPC (35.7%), blaSHV (14.3%), blaCTX-M (14.3%), blaOXA (14.3%), blaTEM (7.1%), blaPER (7.1%), blaVIM (7.1%), and blaVIM-2 (7.1%)] and K. pneumoniae [blaCTX-M (91.7%), blaTEM (83.3%), blaKPC (16.7%), blaNDM (12.5%), and blaOXA (4.2%)]. The results of testing the activity of ε-PL against the clinical isolates showed relatively high minimum inhibitory concentrations (MICs) for the P. aeruginosa (range: 8–64 µg/mL) and K. pneumoniae isolates (range: 16–32 µg/mL). These results suggest the need for prior optimization of ε-PL concerning its viability as an alternative to antibiotics for treating infections caused by P. aeruginosa and K. pneumoniae of clinical origin. It is noteworthy that, in the context of a low antibiotic discovery rate, ε-PL could play a significant role in this quest, considering its low toxicity and the unlikely development of resistance. Upon exposure to ε-PL, P. aeruginosa and K. pneumoniae isolates exhibited a reduction in biofilm production, with ε-PL concentration showing an inverse relationship, particularly in isolates initially characterized as strong or moderate producers, indicating its potential as a natural antimicrobial agent with further research needed to elucidate optimal concentrations and application methods across different bacterial species. Further research is needed to optimize its use and explore its potential in various applications.
Article
Full-text available
Carbapenem-resistant Klebsiella pneumoniae isolates producing K. pneumoniae carbapenemases (KPC) were first reported in the USA in 2001, and since then, this infection has been reported in Europe, Israel, South America, and China. In Korea, the first KPC-2-producing K. pneumoniae sequence type (ST) 11 strain was detected in 2010. We report the case of a patient with a urinary tract infection caused by KPC-2-producing K. pneumoniae. This is the second report of a KPC-2-producing K. pneumoniae infection in Korea, but the multilocus sequence type was ST258. The KPC-2-producing isolate was resistant to all tested β-lactams (including imipenem and meropenem), amikacin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole, but was susceptible to gentamicin, colistin, polymyxin B, and tigecycline. The KPC-2-producing isolate was negative to phenotypic extended-spectrum β-lactamase (ESBL) and AmpC detection tests and positive to modified Hodge test and carbapenemase inhibition test with aminophenylboronic acid.
Article
Full-text available
Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes, including New Delhi metallo-β-lactamase, have been identified among Enterobacteriaceae in the United States. Like KPC, these enzymes are frequently found on mobile genetic elements and have the potential to spread widely. As a result, preventing both CRE transmission and CRE infections have become important public health objectives. This review describes the current epidemiology of CRE in the United States and highlights important prevention strategies.
Article
Full-text available
Carbapenem-resistant gram-negative pathogens represent an emerging threat to the management of hospital-acquired infections. Although the isolation of carbapenem-resistant enterobacteriaceae remains unusual, the frequency of carbapenemases producing Klebsiella pneumoniae is increasing in different geographic regions: the majority of isolates has been collected in the USA, but recently KPC-producing K. pneumoniae were reported from China, Israel, Greece, France, Norway and Sweden. We report a KPC 1-producing K. pneumoniae isolate from Italy. This datum enlarges the geographical area where the KPC-producing K. pneumoniae strains are diffuse.
Article
Full-text available
Prevalence of extended-spectrum beta-lactamases (ESBLs) has limited the available therapeutic options and necessitated the increased use of carbapenems against Klebsiella pneumoniae infections. ...
Article
Full-text available
Accurate detection of antibiotic resistance is essential for patient therapy, infection control and accreditation requirements. This review addresses the controversial issue of whether susceptibility tests alone are sufficient or if special tests (analogous to MRSA detection) are necessary to detect certain resistance mechanisms of gram-negative pathogens. The focus is on pathogens that produce extended spectrum beta-lactamases (ESBLs), plasmid-mediated AmpC beta-lactamases, and carbapenemases.
Article
Full-text available
Clin Microbiol Infect 2010; 16: 112–122 Acquired carbapenemases are emerging resistance determinants in Gram-negative pathogens, including Enterobacteriaceae, Pseudomonas aeruginosa and other Gram-negative non-fermenters. A consistent number of acquired carbapenemases have been identified during the past few years, belonging to either molecular class B (metallo-β-lactamases) or molecular classes A and D (serine carbapenemases), and genes encoding these enzymes are associated with mobile genetic elements that allow their rapid dissemination in the clinical setting. Therefore, detection and surveillance of carbapenemase-producing organisms have become matters of major importance for the selection of appropriate therapeutic schemes and the implementation of infection control measures. As carbapenemase production cannot be simply inferred from the resistance profile, criteria must be established for which isolates should be suspected and screened for carbapenemase production, and for which tests (phenotypic and/or genotypic) should be adopted for confirmation of the resistance mechanism. Moreover, strategies should be devised for surveillance of carbapenemase producers in order to enable the implementation of effective surveillance programmes. The above issues are addressed in this article, as a follow-up to an expert meeting on acquired carbapenemases that was recently organized by the ESCMID Study Group for Antibiotic Resistance Surveillance.
Article
Full-text available
A Pseudomonas fluorescens isolate (PF-1) resistant to carbapenems was recovered during an environmental survey performed with water from the Seine River (Paris). It expressed a novel Ambler class A carbapenemase, BIC-1, sharing 68 and 59% amino acid identities with β-lactamases SFC-1 from Serratia fonticola and the plasmid-encoded KPC-2, respectively. β-Lactamase BIC-1 hydrolyzed penicillins, carbapenems, and cephalosporins except ceftazidime and monobactams. The blaBIC-1 gene was chromosomally located and was also identified in two other P. fluorescens strains isolated from the Seine River 3 months later.
Article
Full-text available
The detection of class A serine-carbapenemases among species of Enterobacteriaceae remains a challenging issue. Methods of identification for routine use in clinical microbiology laboratories have not been standardized to date. We developed a novel screening methodology suitable for countries with high basal levels of carbapenem resistance due to non-carbapenemase-mediated mechanisms and standardized several simple confirmatory methods that allow the recognition of bacteria producing class A carbapenemases, including KPC, Sme, IMI, NMC-A, and GES, by using boronic acid (BA) derivatives. A total of 28 genetically unrelated Enterobacteriaceae strains producing several class A carbapenemases were tested. Thirty-eight genetically unrelated negative controls were included. The isolates were tested against imipenem (IPM), meropenem (MEM), and ertapenem (ETP) by MIC and disk diffusion assays in order to select appropriate tools to screen for suspected carbapenemase production. It was possible to differentiate class A carbapenemase-producing bacteria from non-carbapenemase-producing bacteria by using solely the routine IPM susceptibility tests. The modified Hodge test was evaluated and found to be highly sensitive, although false-positive results were documented. Novel BA-based methods (a double-disk synergy test and combined-disk and MIC tests) using IPM, MEM, and ETP, in combination with 3-aminophenylboronic acid as an inhibitor, were designed as confirmatory tools. On the basis of the performance of these methods, a sensitive flow chart for suspicion and confirmation of class A carbapenemase production in species of Enterobacteriaceae was designed. By using this methodology, isolates producing KPC, GES, Sme, IMI, and NMC-A carbapenemases were successfully distinguished from those producing other classes of beta-lactamases (extended-spectrum beta-lactamases, AmpCs, and metallo-beta-lactamases, etc). These methods will rapidly provide useful information needed for targeting antimicrobial therapy and appropriate infection control.
Article
Antimicrobial resistance in hospital and community-onset bacterial infections is a significant source of patient morbidity and mortality. In the past decade, we have witnessed the increasing recovery of carbapenem-resistant Gram-negative bacteria. For many isolates, carbapenem resistance is due to the production of carbapenemases, β-lactamases that can inactivate carbapenems and frequently other β-lactam antibiotics. Currently, these enzymes are mainly found in three different β-lactamase classes (class A, B and D). Regardless of the molecular classification, there are few antimicrobials available to treat infections with these organisms and data regarding agents in development are limited to in vitro studies. This article focuses on the epidemiology of carbapenemase-producing Gram-negative bacteria. We also review available agents and those in development with potential activity against this evolving threat.